BridgeBio Pharma, Inc. (BBIO)
67.25
+0.34
(+0.51%)
USD |
NASDAQ |
Oct 02, 16:00
67.23
-0.02
(-0.03%)
After-Hours: 20:00
BridgeBio Pharma EPS Diluted (Quarterly) : -0.7775 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7775 |
| March 31, 2026 | -0.8422 |
| December 31, 2025 | -0.9964 |
| September 30, 2025 | -0.9525 |
| June 30, 2025 | -0.9548 |
| March 31, 2025 | -0.8805 |
| December 31, 2024 | -1.399 |
| September 30, 2024 | -0.8596 |
| June 30, 2024 | -0.3916 |
| March 31, 2024 | -0.1971 |
| December 31, 2023 | -0.9638 |
| September 30, 2023 | -1.084 |
| June 30, 2023 | -0.9836 |
| March 31, 2023 | -0.9182 |
| December 31, 2022 | -0.9213 |
| September 30, 2022 | -0.9284 |
| June 30, 2022 | -0.0672 |
| Date | Value |
|---|---|
| March 31, 2022 | -1.346 |
| December 31, 2021 | -1.013 |
| September 30, 2021 | -1.063 |
| June 30, 2021 | -0.6565 |
| March 31, 2021 | -1.176 |
| December 31, 2020 | -1.008 |
| September 30, 2020 | -0.9805 |
| June 30, 2020 | -1.034 |
| March 31, 2020 | -0.7797 |
| December 31, 2019 | -0.6242 |
| September 30, 2019 | -0.5123 |
| June 30, 2019 | -0.7101 |
| March 31, 2019 | -0.4974 |
| December 31, 2018 | -0.4448 |
| September 30, 2018 | -0.5152 |
| June 30, 2018 | -0.2604 |
| March 31, 2018 | -0.3031 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Ionis Pharmaceuticals, Inc. | -0.6931 |
| Pfizer Inc. | -0.0435 |
| BioMarin Pharmaceutical, Inc. | 0.2302 |
| Vertex Pharmaceuticals, Inc. | 4.310 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -155.89M |
| Revenue (Quarterly) | 243.68M |
| Total Expenses (Quarterly) | 395.89M |
| Enterprise Value | 15.82B |
| Gross Profit Margin (Quarterly) | 93.68% |
| Profit Margin (Quarterly) | -63.97% |
| Earnings Yield | -5.31% |
| Normalized Earnings Yield | -5.306 |